REGENXBIO Inc. – Filings and Transcripts

NASDAQ: RGNX
Share price (7/8/26): $15.23
Market cap (7/8/26): $787 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 03/31/26 Q1

ended 12/31/25 FY 2025

ended 09/30/25 Q3

ended 06/30/25 Q2

ended 03/31/25 Q1

Prospectuses and Registrations Filter

Issuer tender offer – amended

Issuer tender offer – amended

Issuer tender offer

Prospectus supplement for primary offering

Shelf registration

Ownership Filter

JPMorgan Chase & Co.

News Filter

Announces First Patient Dosed in Phase IIb/III NAAVIGATE Trial of Surabgene Lomparvovec in Diabetic Retinopathy; Company to Receive $100 Million Milestone

Shareholder Vote Results, Other Events

Reports First Quarter 2026 Financial Results and Operational Highlights

Material Definitive Agreement

Reports Fourth Quarter and Full Year 2025 Financial Results and Operational Highlights

Proxies Filter

Additional info about upcoming vote

Definitive proxy

Preliminary proxy

Additional info about upcoming vote

Definitive proxy

Other Filter

Scanned paper annual report submission

Notice of effectiveness

Correspondence with the SEC

Notice of effectiveness

Correspondence with the SEC